ArticleScientific reports2017

A canine chimeric monoclonal antibody targeting PD-L1 and its clinical efficacy in canine oral malignant melanoma or undifferentiated sarcoma.

Naoya Maekawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.